Who Are Oregon's First Legal Psilocybin Facilitators? An Early Survey, Two Years On
When Oregon created the first legal framework for supervised psilocybin services outside of traditional health care and research settings, one of the biggest open questions was simple: who would actually provide these services? A couple of years ago, I was part of a team of researchers at Portland Psychotherapy that set out to answer it. We surveyed people who had completed or were enrolled in Oregon Health Authority–approved psilocybin facilitator training programs, hoping to understand who these early facilitators were, what their training experiences were like, and how they planned to practice once licensed.
That study captured a snapshot of a brand-new profession at its very beginning. Now that Oregon's program has been operating for more than two years, I want to revisit what we found — and reflect on how much the landscape has changed, and what the field needs next.
A New Kind of Psychedelic Provider
Oregon's model is different from psychedelic-assisted therapy in clinical trials, where treatment is usually delivered by licensed health care professionals in tightly controlled research settings. In Oregon, adults 21 and older can access supervised psilocybin services through licensed service centers. Facilitators complete state-approved training and may provide preparation, administration, and integration services, but the model exists outside traditional medical treatment.
This is exactly why we felt the workforce was so important to study. The safety, effectiveness, and accessibility of psilocybin services depend in part on who becomes a facilitator, what training they receive, and whether services are financially and culturally accessible to the public.
What Did Training Look Like?
We reviewed 16 active training programs approved by the Oregon Health Authority. Training costs ranged from $4,500 to $12,000, with an average of $9,359. Programs generally combined coursework and practicum experience, with many built around Oregon's minimum requirements of 120 hours of didactic training and 40 hours of practicum.
Half of the programs offered scholarships intended to promote diversity, equity, and inclusion. Even so, cost was a major concern. Among the facilitators we surveyed, the median amount spent or expected to be spent on training was $9,500, and 79% said training costs caused at least moderate or severe financial strain.
Who Were the Early Facilitators?
Our sample included 106 eligible respondents from nine training programs who intended to practice in Oregon. In some ways, the group was relatively diverse: about 64% identified as White and 36% as people of color, and gender identity was reported as 40% women, 40% men, and 20% other, including LGBTQ+ or preferred not to answer. Many were highly educated, with nearly three-quarters reporting graduate degrees.
More than half reported holding a health care license or certification, with common backgrounds in licensed professional counseling, acupuncture, psychology, and medicine. Many also had experience with Indigenous practices or psychedelic harm reduction services.
High Satisfaction, But Ongoing Needs
Overall, most respondents were satisfied with their training. Many felt prepared to work as facilitators — to identify people who should not be offered psilocybin services, counsel clients about risks, and handle adverse outcomes.
At the same time, they pointed to clear gaps. Some wanted more mentorship, more practicum opportunities, more in-person training, and more education on psychedelic risk reduction. Others felt programs would benefit from more diverse students, instructors, and content. Nearly everyone expressed interest in continuing education.
That last finding has since been borne out in policy: as of January 2026, Oregon requires facilitators to complete at least four hours of continuing education each year to renew their license. The instinct our respondents voiced early on — that this is a field where learning can't stop at licensure — is now starting to be built into the system.
Concerns About Access and Affordability
At the time, one of our biggest concerns was about who would be able to participate — both as facilitators and as clients. If only people with substantial financial resources could afford training, we worried the workforce might become less representative over time, making it harder to provide culturally responsive care. And on the client side, facilitators told us they planned to charge an average of $1,388 per session (median $900) — costs that could put services out of reach for many.
Two years later, that concern is no longer hypothetical. State data released in 2025 suggest that people accessing Oregon psilocybin services skew significantly wealthier than the general population — with an estimated average client income around $136,000, compared to roughly $88,000 for Oregon households — and skew heavily toward White and European backgrounds, with very few rural or disabled clients. Real-world session prices commonly run from about $1,000 to $3,000 and are not covered by insurance, though lower-cost group and equity-based options (starting around $700) have begun to emerge, along with financial assistance from nonprofits like the Sheri Eckert Foundation.
The state has taken some steps to monitor the problem: Senate Bill 303 now requires service centers to collect and report client demographic data each quarter, and all facilitators and centers must maintain equity plans as a condition of license renewal. Whether these measures meaningfully widen access remains an open question.
Two Years On: A Harder Reality for Service Centers
The challenge I didn't fully anticipate was economic survival. By 2025, roughly a third of Oregon's licensed service centers had closed, squeezed by high operating costs — a $10,000 annual license fee, along with mandated security and storage requirements. The program has not been self-sustaining on licensing fees alone; the state had to draw about $3.1 million from its general fund to keep it operating.
The workforce we studied has felt this too. More than 100 facilitators have let their licenses lapse since the program began, a sobering counterpoint to the optimism and high satisfaction we documented in that first cohort. In response, Oregon passed House Bill 2387, effective January 2026, which allows licensed health care providers who also hold facilitator licenses to practice without risking discipline from their professional boards, a change that speaks directly to how many of our respondents came from clinical backgrounds.
Oregon Is No Longer Alone
When we ran our survey, Oregon was the only state with a legal psilocybin services framework. That's no longer true. Colorado launched its Natural Medicine program in 2025, licensing its first facilitators early in the year and its first healing center that April. New Mexico followed with a Medical Psilocybin Act — the first such program created through legislation rather than a ballot measure — which notably includes a state equity fund (roughly $630,000) to help subsidize treatment for low-income patients, something Oregon's model still lacks.
These newer programs are learning from Oregon's experience, which makes our early findings about workforce, cost, and access even more relevant beyond state lines.
What the Field Needs Now
Looking back, our survey captured a workforce that was optimistic, well-educated, and genuinely committed to doing this work well. Those strengths are still there. But the last two years have made the harder questions unavoidable: How do service centers stay financially viable? How do clients pay for care when insurance won't cover it? How do we build a workforce and a client base that actually reflects the communities these services are meant to serve? And how do we keep skilled facilitators in the field once they're trained?
Oregon now holds one of the largest bodies of real-world data on regulated psilocybin use anywhere in the world, which is an extraordinary opportunity. Building a safe, effective, and equitable system will depend not just on strong training and clear regulation, but on sustainable economics, accessible pathways into and through care, and ongoing research on how facilitators are prepared to support diverse communities. The future of psilocybin services will hinge not only on the rules we write, but on who is able to provide care — and who is able to receive it.
Author: Jason Luoma, PhD
Jason Luoma, PhD, is the Director of Research at the Portland Institute for Psychedelic Science (PIPS) and a co-founder of Portland Psychotherapy. His research focuses on psychedelic-assisted therapy, shame, and Acceptance and Commitment Therapy (ACT). He led the survey research team that produced the original facilitator workforce study and co-authored the resulting publication in the Journal of Psychoactive Drugs. He also hosts the Research Matters Podcast.